According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Randomized controlled trial with metabolite blockade
If mice given oral hyaluronan show skin/joint benefits only when metabolites are allowed to form, but not when metabolite production is blocked (e.g., via enzyme inhibitors), while intact hyaluronan is still present, this would support the claim. Isotope-traced metabolite tracking with tissue-specific analysis
If labeled hyaluronan metabolites (e.g., 13C-glucuronic acid) are detected in skin and joint tissues after oral intake, while intact hyaluronan is not, this would support metabolite-mediated effects. Genetic knockout of hyaluronan receptor comparison
If mice lacking receptors for hyaluronan metabolites (e.g., CD44, TLR2/4) show no skin/joint benefits from oral hyaluronan, but wild-type mice do, this implies metabolites act via specific receptors. Oral hyaluronan vs. oral metabolite supplementation comparison
If purified hyaluronan metabolites (e.g., oligosaccharides) replicate the skin/joint effects of intact hyaluronan when given orally, but intact hyaluronan does not when administered in a form resistant to degradation, this supports the metabolite hypothesis. In vitro cell culture with isolated metabolites
If mouse dermal fibroblasts or chondrocytes respond to hyaluronan metabolites (but not intact HA) with anti-inflammatory or matrix-boosting signals, this supports a direct cellular mechanism.